Trial Profile
Effects of acute glucocorticoid blockade on metabolic dysfunction in patients with Type 2 diabetes with and without fatty liver.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Metyrapone (Primary) ; Mifepristone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 07 Dec 2015 New trial record